United States v. Manjit Kaur

382 F.3d 1155, 2004 U.S. App. LEXIS 19073, 2004 WL 2021279
CourtCourt of Appeals for the Ninth Circuit
DecidedSeptember 10, 2004
Docket03-30306
StatusPublished
Cited by22 cases

This text of 382 F.3d 1155 (United States v. Manjit Kaur) is published on Counsel Stack Legal Research, covering Court of Appeals for the Ninth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Manjit Kaur, 382 F.3d 1155, 2004 U.S. App. LEXIS 19073, 2004 WL 2021279 (9th Cir. 2004).

Opinion

PREGERSON, Circuit Judge:

Manjit Kaur was convicted of possessing and distributing pseudoephedrine knowing or having “reasonable cause to believe” that it would be used to manufacture methamphetamine in violation of 21 U.S.C. § 841(c)(2). 1 On appeal, Ms. Kaur challenges the district court’s jury instruction explaining the meaning of the reasonable cause to believe mental state found in that statute (“Instruction 17”). 2 This circuit has not previously interpreted that statutory mens rea requirement. We hold that the district court did not abuse its discretion in formulating Instruction 17, which fairly and accurately described the required mental state.

I. Background

Appellant Manjit Kaur owned a convenience store in Spokane, Washington. In June 2002, a confidential source working with the Drug Enforcement Agency purchased large quantities of pseudoephedrine at Ms. Kaur’s store. As a result, Ms. Kaur was charged with distributing pseu-doephedrine knowing or having reasonable cause to believe that it would be used to make methamphetamine. Agents later seized additional pseudoephedrine from her store, and Ms. Kaur was charged with possessing pseudoephedrine knowing or having reasonable cause to believe that it would be used to manufacture methamphetamine.

Ms. Kaur and the government each proposed a jury instruction regarding the reasonable cause to believe standard in 21 U.S.C. § 841(c)(2). The district court rejected both. Instead, the district court formulated Instruction 17: “ ‘Reasonable cause to believe’ means to have knowledge of facts which, although not amounting to direct knowledge, would cause a reasonable person knowing the same facts, to reasonably conclude that the pseudoephed-rine would be used to manufacture a controlled substance.” 3

The jury found Ms. Kaur guilty on all counts. 4

*1157 II. Standard of Review

We “review[ ] jury instructions as a whole to determine whether they are misleading or inadequate to guide the jury’s deliberation.” United States v. Vallejo, 237 F.3d 1008, 1024 (9th Cir.2001). We review de novo whether an instruction misstated an element of the charged offense, and review for abuse of discretion the district court’s formulation of instructions. United States v. Stapleton, 293 F.3d 1111, 1114(9th Cir.2002).

III. Discussion

The district court’s instruction reveals no abuse of discretion.

In United States v. Saffo, the Tenth Circuit held that the “knowing or having reasonable cause to believe” standard in 21 U.S.C. § 841(d)(2) (now found at 21 U.S.C. § 841(c)(2)) “imposes a constitutionally sufficient mens rea requirement.” 227 F.3d 1260, 1268 (10th Cir.2000). After announcing this holding, the Saffo court elaborated on the “reasonable cause to believe” standard:

we note that the standard involves a subjective inquiry that looks to whether the particular defendant accused of the crime knew or had reasonable cause to believe the listed chemical would be used to manufacture a controlled substance. This requires scienter to be evaluated through the lens of this particular defendant, rather than from the perspective of a hypothetical reasonable man. In this context, the “reasonable cause to believe” standard is akin to actual knowledge.

Id. at 1268-69 (citation omitted).

As a preliminary matter, the district court appropriately rejected Ms. Kaur’s proposed instruction, which effectively equated reasonable cause to believe with actual knowledge. Congress did not likely have in mind Ms. Kaur’s proposed interpretation of 21 U.S.C. § 841(c)(2) because the statute clearly presents knowledge and reasonable cause to believe as two distinct alternatives; reasonable cause to believe would be superfluous if it meant knowledge. See Connecticut Nat’l Bank v. Germain, 503 U.S. 249, 253, 112 S.Ct. 1146, 117 L.Ed.2d 391 (1992) (“[Cjourts should disfavor interpretations of statutes that render language superfluous.”).

We are not persuaded by Ms. Kaur’s contention that Instruction 17 improperly imposed a reasonable person standard rather than a subjective standard. The district court’s formulation does not replace a subjective standard with an objective reasonable person standard. Rather, consistent with the text of the statute, the instruction incorporates both subjective and objective considerations. The district court instructed the jury to evaluate whether Ms. Kaur knew or had reasonable cause to believe that the pseudoephedrine she possessed and distributed would be used to manufacture methamphetamine. That is a subjective inquiry. The district court then offered the jury guidance as to the meaning of reasonable cause to believe to explain how this alternative mens rea differed from (the more easily understood) actual knowledge. The district court explained that this standard incorporates both subjective and objective elements: Ms. Kaur had reasonable cause to believe if she actually knew facts that would alert a reasonable person that the pseudoephed-rine would be used to make methamphetamine. The district court’s instruction *1158 simply elaborated upon the statutory language: the government had to prove that Ms. Kaur either knew, or knew facts that would have made a reasonable person aware, that the pseudoephedrine would be used to make methamphetamine. 5 Thus, the district court did not abuse its discretion in formulating Instruction 17. 6

1

. Pseudoephedrine is a chemical substance found in over-the-counter cold medications. Because it can be used to manufacture the illegal drug methamphetamine, pseudoephed-rine is a listed chemical under the Controlled Substances Act. See 21 U.S.C. § 802(34)(K).

2

.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In re Way to Grow, Inc.
597 B.R. 111 (D. Colorado, 2018)
SIERRA
26 I. & N. Dec. 288 (Board of Immigration Appeals, 2014)
United States v. Lan Thi Tran Nguyen
502 F. App'x 678 (Ninth Circuit, 2012)
United States v. Kenia Munguia
704 F.3d 596 (Ninth Circuit, 2012)
United States v. Thongsy
577 F.3d 1036 (Ninth Circuit, 2009)
United States v. Khattab
536 F.3d 765 (Seventh Circuit, 2008)
United States v. Morales-Estrada
244 F. App'x 138 (Ninth Circuit, 2007)
United States v. Karawi
213 F. App'x 570 (Ninth Circuit, 2006)
United States v. Truong
425 F.3d 1282 (Tenth Circuit, 2005)
United States v. Joga Singh Johal
421 F.3d 955 (Ninth Circuit, 2005)
United States v. Johal
Ninth Circuit, 2005
United States v. Yamina Abigail Munoz
412 F.3d 1043 (Ninth Circuit, 2005)
United States v. Munoz
Ninth Circuit, 2005
United States v. Louis D. Galvan
407 F.3d 954 (Eighth Circuit, 2005)
United States v. Abramov
119 F. App'x 100 (Ninth Circuit, 2004)

Cite This Page — Counsel Stack

Bluebook (online)
382 F.3d 1155, 2004 U.S. App. LEXIS 19073, 2004 WL 2021279, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-manjit-kaur-ca9-2004.